Fund
b2venture
b2venture took part in the round of Everlab (65 M AU$, Series A) on 18 June 2026. It is the only health round Bolus has logged for it so far.
Page built from the operations logged, not from a written profile. It says nothing about the fund's activity outside the scope of Bolus, which is health venture capital in Europe and the United States.
- Operations logged
- 1
- Lead
- 0
- New entries
- 1
- Follow ons
- 0
- Latest operation
- 18 June 2026
- Sectors
- Health services
Operations
| Date | Company | Stage | Amount | Role |
|---|---|---|---|---|
| 18 Jun | Australia, Health services | Series A | 65 M AU$ | Participant |
Co investors 3 funds crossed
Funds that appeared in the same rounds, in any capacity. Geographies logged: Australia.